MedDataX Logo

Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19

NCT ID: NCT04456075

Last Updated: 2020-07-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-04-01

Study Completion Date

2022-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Approximately 15% of patients with SARS-CoV-2 infection / COVID-19 develop a severe clinical course. This leads to hospitalization and potentially life threatening complications such as pneumonia and respiratory failure. Predictors for early detection and risk stratification are urgently needed. Moreover, only scarce information is available for long-term follow-up and late complications associated with infection. We therefore aimed to find predictors for severe courses of the novel disease as well as to establish strategies for therapeutic monitoring and follow-up.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Testing for COVID-19 Infection in Asymptomatic Persons

NCT04345510

COVID-19 Infection
COMPLETED

Prospective Evaluation of the Predictive Criteria of Severity for Respiratory Infection Due to COVID-19 Virus

NCT04615676

SARS-CoV2
COMPLETED

Long-Term Experience and Health Effects of COVID-19

NCT04477902

Covid19 Corona Virus Infection Quality of Life +1 more
COMPLETED

Nasal and Pulmonary Nitric Oxide Output in COVID-19 Infection

NCT04728919

COVID-19 SARS-CoV-2 Infection
UNKNOWN

Predictive Immune Biomarkers of COVID-19 Pathogenesis to Influence Therapeutic Management

NCT04668170

COVID-19
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

SARS-CoV2 COVID

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* SARS-CoV-2 infection / COVID 19

Exclusion Criteria

* invasive ventilation
* respiratory failure at admission
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Heidelberg University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Frederik Trinkmann

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Frederik Trinkmann, MD

Role: PRINCIPAL_INVESTIGATOR

Thoraxklinik at Heidelberg University

Felix JF Herth, MD

Role: STUDY_DIRECTOR

Thoraxklinik at Heidelberg University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Thoraxklinik at Heidelberg University

Heidelberg, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Frederik Trinkmann, MD

Role: CONTACT

[email protected]
+49 6221 396 ext. 1201

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Frederik Trinkmann, MD

Role: primary

[email protected]
+ 49 6221 396 ext. 1201

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CROWNLESS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Risk Factors for COVID-19 Mortality
NCT04786808 TERMINATED
Comorbidities and Risk Score in COVID-19 Patients
NCT04670094 COMPLETED
Caracterisation of COVID-19 Patients Hospitalized in Infectious Disease Department
NCT04779021 UNKNOWN
A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe Illness
NCT05661604 COMPLETED
Observation of Initial Procalcitonin and the Clinical Course of Patients With Acute Respiratory Tract Infections
NCT00827060 COMPLETED
Recovery of Respiratory System in COVID-19 Patients
NCT04954222 COMPLETED
Risk Factors Worsening COVID19 for Out-patient With Home Monitoring
NCT04380662 UNKNOWN
Detect Novel Pathogens and Characterize Emerging Infections
NCT01979705 UNKNOWN
A Novel Nomogram to Predict Severity of COVID-19
NCT04366024 COMPLETED
Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia - COVID-19
NCT04376840 COMPLETED NA
Respiratory Virus Infections in Acutely Hospitalized Adult Patients With Pulmonary and Extrapulmonary Complications
NCT03816059 UNKNOWN
Pandemic Triage Score in Patients With Known or Suspected Severe Acute Respiratory Syndrome (SARS) CoronaVirus (CoV) 2 Infection
NCT04371471 COMPLETED
COVID-19 Clinical Status Associated With Outcome Severity: An Unsupervised Machine Learning Approach
NCT05119465 COMPLETED
Health Professional Exposure Assessment to Covid-19
NCT04429724 COMPLETED NA
Follow-up of Patients With Previous SARS-CoV-2 Infection: Long-term Damage Assessment
NCT05359159 RECRUITING
The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications
NCT04453748 UNKNOWN
Observational, Prospective Clinical Study to Evaluate Biomarkers as Indicators of Acute Bacterial or Viral Infections
NCT01917461 COMPLETED
Follow-up of Respiratory Sequelae of Hospitalized Patients With COVID-19
NCT04505631 COMPLETED
COVID-Like Illness Respiratory Pathogens. A Prospective Cohort on the COVID-19 Post-acute Condition
NCT05047666 UNKNOWN
Mechanisms for Covid-19 Disease Complications
NCT04314232 UNKNOWN
Covid-19 Associated Coagulopathy Predicted by Thrombodynamic Markers (CoViTro-I)
NCT05330832 UNKNOWN
Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19
NCT04912895 COMPLETED NA
Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection
NCT04527614 COMPLETED NA
The Natural History of Hospitalized COVID-19 Patients
NCT04424992 RECRUITING
Clinical Course and Treatment of COVID-19 Inpatients in Hospital
NCT04527497 COMPLETED